Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬
Learn more about his innovative research to make immune-resistant tumors responsive!
Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬
Learn more about his innovative research to make immune-resistant tumors responsive!
Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects.
Listen to the interview: www.youtube.com/watch?v=ARPz...
Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects.
Listen to the interview: www.youtube.com/watch?v=ARPz...